Tangent90 Strengthens Account Management Team

London, United Kingdom – 09 March 2022: Tangent90 Ltd, a leading technology company that enables pharma to overcome the challenges of sharing scientific digital content with healthcare professionals, welcome the appointment of John Robson as Account Director.

John joins Tangent90 Limited from huumun Ltd where, in a Business Development and Account Management role, he supported multiple pharmaceutical clients in the development of digital solutions including web, CLM and e-detailing solutions as part of their wider digital eco-system.

“I am really excited to be joining Tangent90, at a time where we are seeing the true potential and growth of engagement through the distribution of copyright scientific content,” John explained. “I look forward to working with the team in delivering solutions that lead to greater and more meaningful engagement with Healthcare Professionals using their digital channels of choice”, he added.

“We are experiencing a significant period of growth and with that the need to rapidly scale the team to ensure we are able to continue delivering a high-quality service for clients”, explained Jan van den Burg, CEO, Tangent90. “John brings extensive digital experience in the healthcare and life sciences industry which will prove valuable for our customers as well as our internal team”, he added.

>> Download Full Article

Related news

Medical journal

Why relevance and impact are so important for HCPs

Making an impact attracts attention. Doesn’t it? Well, yes but only if the subject of the impact is relevant to the person being impacted. For it to resonate, it needs to be timed to perfection and the subject be of specific relevance to the recipient.

T90 Perspective

The omnichannel revolution

Omnichannel is more than just a buzzword. It is influencing the customer journey in pharma. Adding published scientific content to your omnichannel strategy can help add greater value for HCPs. Read the T90 perspective>>

Scroll to Top

We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.